Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ·Healthcare·Biotechnology
$6.97
-0.07%
Mkt Cap $235.91M
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (14 analysts)
$22.50
Range $20.00 – $25.00
Implied Upside
+223.0%
Consensus $22.50 vs current $6.97